Jonathan Tan currently leads Patients Access in Asia focusing on transforming the patient’s journey to healthcare. This includes going “beyond the pill” through the development of innovative financing models and end-to-end management programs leveraging connectivity, data analytics, and AI.
His previous role was as the Director in Oliver Wyman, a global management consultancy, where he lead their research on the healthcare, insurance, and societal impact of aging populations.
Prior to this, he was Head of HEOR Asia Pacific for Allergan. Before this, he worked in Market Access and Health Economics Australia.
Jonathan holds a B.Sc from University of Western Australia, PhD (Biostatistics & Epidemiology) from the National University of Singapore, and MBA from University of Newcastle.